Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Sovaldi in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

NCT02907996 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02907996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02907996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Sovaldi in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
September 9, 2016
Completion date
December 9, 2021
Enrollment
2,033 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus